Literature DB >> 9211128

Recurrent thromboembolism as a hallmark of Cushing's syndrome.

A La Brocca1, M Terzolo, A Pia, P Paccotti, P De Giuli, A Angeli.   

Abstract

The present report describes a 54-year-old woman with a history of recurrent thromboembolic events. The clinical and physical examination led to suspect Cushing's syndrome. Screening tests (urinary free cortisol excretion and 1 mg dexamethasone) were inconclusive, but a detailed endocrine work up confirmed the presence of ACTH-dependent hypercortisolism. The patient was cured by the removal of a ACTH-secreting microadenoma by transsphenoidal route. The present case provides a clinical demonstration of a previous experimental evidence that a hypercoagulable state is present in Cushing's syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9211128     DOI: 10.1007/BF03346905

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  18 in total

1.  The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state.

Authors:  G M Patrassi; M T Sartori; M L Viero; L Scarano; M Boscaro; A Girolami
Journal:  Blood Coagul Fibrinolysis       Date:  1992-12       Impact factor: 1.276

2.  Thromboembolic complications, heparin treatment in increase in coagulation factors in Cushing's syndrome.

Authors:  H E Sjöberg; M Blombäck; P O Granberg
Journal:  Acta Med Scand       Date:  1976

3.  Operative treatment, surgical approach, and related complications in 195 operations upon the adrenal glands.

Authors:  M Blichert-Toft; A Bagerskov; K Lockwood; E Hasner
Journal:  Surg Gynecol Obstet       Date:  1972-08

4.  Cyclic Cushing's syndrome combined with cortisol suppressible, dexamethasone non-suppressible ACTH secretion: a new variant of Cushing's syndrome.

Authors:  H U Schweikert; H L Fehm; R Fahlbusch; R Martin; R Kolloch; M Higuchi; F Krück
Journal:  Acta Endocrinol (Copenh)       Date:  1985-11

5.  Increased concentration of the fast-acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis.

Authors:  M Jørgensen; V Bonnevie-Nielsen
Journal:  Br J Haematol       Date:  1987-02       Impact factor: 6.998

6.  The contact phase of blood coagulation and renin activation in essential hypertension before and after captopril.

Authors:  G M Patrassi; F Fallo; S Martinelli; F Mantero; G Boeri; A Girolami
Journal:  Eur Heart J       Date:  1984-07       Impact factor: 29.983

7.  Increased proteolysis. An effect of increases in plasma cortisol within the physiologic range.

Authors:  P S Simmons; J M Miles; J E Gerich; M W Haymond
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

8.  Familial hypofibrinolysis and venous thrombosis.

Authors:  J Petäjä; V Rasi; G Myllylä; E Vahtera; H Hallman
Journal:  Br J Haematol       Date:  1989-03       Impact factor: 6.998

9.  Haemostatic parameters in Cushing's syndrome.

Authors:  E Ikkala; G Myllylä; R Pelkonen; V Rasi; L Viinikka; O Ylikorkala
Journal:  Acta Med Scand       Date:  1985

10.  Diabetes, a hypercoagulable state? Hemostatic variables in newly diagnosed type 2 diabetic patients.

Authors:  A Hughes; B A McVerry; L Wilkinson; A H Goldstone; D Lewis; A Bloom
Journal:  Acta Haematol       Date:  1983       Impact factor: 2.195

View more
  10 in total

1.  Von Willebrand factor and fibrinolytic parameters during the desmopressin test in patients with Cushing's disease.

Authors:  Francesca Pecori Giraldi; Alberto G Ambrogio; Letizia M Fatti; Valentina Rubini; Giovanna Cozzi; Massimo Scacchi; Augusto B Federici; Francesco Cavagnini
Journal:  Br J Clin Pharmacol       Date:  2011-01       Impact factor: 4.335

2.  CUSHING'S SYNDROME, A RISK FACTOR FOR VENOUS THROMBOEMBOLISM IS A CANDIDATE FOR GUIDELINES.

Authors:  G Koraćević; M Stojanović; S Petrović; D Simić; D Sakač; M Vlajković; M Stevic; M Kocić; M Đorđević; M Koraćević
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Apr-Jun       Impact factor: 0.877

3.  Intracranial venous thrombosis after placement of a lumbar drain.

Authors:  Mitchell G Miglis; David N Levine
Journal:  Neurocrit Care       Date:  2010-02       Impact factor: 3.210

4.  Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers.

Authors:  Darko Kastelan; Tina Dusek; Ivana Kraljevic; Ozren Polasek; Zlatko Giljevic; Mirsala Solak; Silva Zupancic Salek; Jozo Jelcic; Izet Aganovic; Mirko Korsic
Journal:  Endocrine       Date:  2009-04-21       Impact factor: 3.633

Review 5.  The coagulation system in endocrine disorders: a narrative review.

Authors:  A Squizzato; V E A Gerdes; W Ageno; H R Büller
Journal:  Intern Emerg Med       Date:  2007-07-09       Impact factor: 3.397

6.  Venous thromboembolism in patients with Cushing's syndrome: need of a careful investigation of the prothrombotic risk profile.

Authors:  S Koutroumpi; V Daidone; M T Sartori; M G Cattini; N M Albiger; G Occhi; S Ferasin; A Frigo; F Mantero; A Casonato; C Scaroni
Journal:  Pituitary       Date:  2013-06       Impact factor: 4.107

7.  Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels.

Authors:  C Erem; I Nuhoglu; M Yilmaz; M Kocak; A Demirel; O Ucuncu; H Onder Ersoz
Journal:  J Endocrinol Invest       Date:  2009-02       Impact factor: 4.256

8.  Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome.

Authors:  L M Fatti; B Bottasso; C Invitti; R Coppola; F Cavagnini; P M Mannucci
Journal:  J Endocrinol Invest       Date:  2000-03       Impact factor: 5.467

9.  Hypertension and other morbidities with Cushing's syndrome associated with corticosteroids: a review.

Authors:  Melpomeni Peppa; Maria Krania; Sotirios A Raptis
Journal:  Integr Blood Press Control       Date:  2011-03-03

10.  Thromboelastometry in veal calves to detect hemostatic variations caused by low doses of dexamethasone treatment.

Authors:  Antonio Borrelli; Claudio Bellino; Elena Bozzetta; Barbara Bruno; Sara Falco; Cristiana Maurella; Paola Gianella; Marzia Pezzolato; Aurelio Cagnasso; Antonio D'Angelo
Journal:  BMC Vet Res       Date:  2013-03-26       Impact factor: 2.741

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.